BeOne Medicines (ONC) Cash from Investing Activities Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -674.01% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -166.24% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -122.45% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 62.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.68% |
| Dec 31, 2025 | 59.05% |
| Sep 30, 2025 | 63.20% |
| Jun 30, 2025 | 40.01% |
| Mar 31, 2025 | 41.89% |
| Dec 31, 2024 | -49.57% |
| Sep 30, 2024 | 28.13% |
| Jun 30, 2024 | -263.76% |
| Mar 31, 2024 | -187.04% |
| Dec 31, 2023 | -262.40% |
| Sep 30, 2023 | -209.91% |
| Jun 30, 2023 | -89.71% |
| Mar 31, 2023 | 14.58% |
| Dec 31, 2022 | 281.68% |
| Sep 30, 2022 | 1,512.96% |
| Jun 30, 2022 | 161.81% |
| Mar 31, 2022 | -27.93% |
| Dec 31, 2021 | 75.60% |
| Sep 30, 2021 | 99.22% |
| Jun 30, 2021 | 158.52% |
| Mar 31, 2021 | 126.18% |
| Dec 31, 2020 | -263.82% |
| Sep 30, 2020 | -819.27% |
| Jun 30, 2020 | -323.89% |
| Mar 31, 2020 | -746.67% |
| Dec 31, 2019 | -111.20% |
| Sep 30, 2019 | 143.54% |
| Jun 30, 2019 | 462.55% |
| Mar 31, 2019 | 143.72% |
| Dec 31, 2018 | 412.48% |
| Sep 30, 2018 | -22.25% |
| Jun 30, 2018 | -51.03% |
| Mar 31, 2018 | -1,005.66% |
| Dec 31, 2017 | 60.03% |
| Sep 30, 2017 | -1,010.53% |
| Jun 30, 2017 | 151.43% |
| Mar 31, 2017 | 7.93% |
| Dec 31, 2016 | -2,437.98% |
| Sep 30, 2016 | 604.76% |
| Jun 30, 2016 | -79.08% |
| Mar 31, 2016 | 1,148.62% |